Under the structure of the transaction, the aggregate investment amount will be up to $15 million invested in two tranches of $7.5 million each and divided among a group of institutional and accredited investors in varying percentages.
More Articles on Orthopedic Devices:
40 Orthopedic & Spine FDA 510(k) Device Clearances in July
Misonix Adds 6 Spine Sales Agencies
FDA Proposes New 510(k) Process to Ensure Application Completeness
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
